Ustar Biotechnology, based in Hangzhou, China, is a molecular diagnostic company dedicated to developing, manufacturing, and marketing rapid nucleic acid diagnostic products for point-of-care. The company holds fifteen China, U.S., Japan patents for novel molecular technologies, including disposable nucleic acid(NA) extraction device, cross-priming isothermal amplification (CPA), disposable contamination-proof DNA detection device, and reagent glassification. Combining them, Ustar offers pathogen NA detection platforms and SNP/Mutation detection platform that can be transformed into rapid molecular diagnostic kits for Point-of-Care diagnostics or on-spot testing. The isothermal testing requires no PCR machine and molecular lab, enabling molecular testing possible in the low-resources setting with quick results. Several diagnostics had been developed for the detection of TB, TB multidrug-resistance (TB-MDR), STD, etc. Applications cover hospital, CDC and Import & Export Quarantines, etc. Ustar’s main office and manufacturing facilities are located in Binjiang District, Hangzhou, China. The new 2,000 square meters facilities includes a 800 square meters 100K grade clean room area, with a designed production capacity of 20 million tests per year. The facility is constructed and equipped with state-of-the-art technology and is ISO9001:2003, ISO13485:2003 + AC: 2007 certified.